These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11836119)

  • 1. Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.
    Pizarro N; de la Torre R; Farré M; Segura J; Llebaria A; Joglar J
    Bioorg Med Chem; 2002 Apr; 10(4):1085-92. PubMed ID: 11836119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
    Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R
    J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
    Mueller M; Yuan J; Felim A; Neudörffer A; Peters FT; Maurer HH; McCann UD; Largeron M; Ricaurte GA
    Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
    Schindler CW; Thorndike EB; Blough BE; Tella SR; Goldberg SR; Baumann MH
    Br J Pharmacol; 2014 Jan; 171(1):83-91. PubMed ID: 24328722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.
    Segura M; Ortuño J; Farré M; McLure JA; Pujadas M; Pizarro N; Llebaria A; Joglar J; Roset PN; Segura J; de La Torre R
    Chem Res Toxicol; 2001 Sep; 14(9):1203-8. PubMed ID: 11559034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain.
    Mueller M; Peters FT; Ricaurte GA; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):119-24. PubMed ID: 18829400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
    Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
    Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
    Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
    J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma.
    Mueller M; Peters FT; Ricaurte GA; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):262-70. PubMed ID: 17646137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA ("ecstasy") from R-(-)- and S-(+)-N-methyl-α-methyldopamine precursors.
    Martinez CM; Neudörffer A; Largeron M
    Org Biomol Chem; 2012 May; 10(18):3739-48. PubMed ID: 22456797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): comparison with related catecholamines.
    Felim A; Herrera G; Neudörffer A; Blanco M; O'Connor JE; Largeron M
    Chem Res Toxicol; 2010 Jan; 23(1):211-9. PubMed ID: 20017534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases.
    Schwaninger AE; Meyer MR; Zapp J; Maurer HH
    Toxicol Lett; 2011 Apr; 202(2):120-8. PubMed ID: 21295122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
    Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants.
    Antolino-Lobo I; Meulenbelt J; Molendijk J; Nijmeijer SM; Scherpenisse P; van den Berg M; van Duursen MB
    Toxicology; 2011 Nov; 289(2-3):175-84. PubMed ID: 21871945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of MDMA and its three metabolites in the rat perfused liver.
    Jamali B; Ardakani YH; Foroumadi A; Kobarfard F; Rouini MR
    J Anal Toxicol; 2013; 37(6):357-61. PubMed ID: 23729636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach.
    Schwaninger AE; Meyer MR; Maurer HH
    Drug Metab Dispos; 2011 Nov; 39(11):1998-2002. PubMed ID: 21795466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
    Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective determination of 3,4-methylene-dioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis.
    Lanz M; Brenneisen R; Thormann W
    Electrophoresis; 1997 Jun; 18(6):1035-43. PubMed ID: 9221895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
    Schwaninger AE; Meyer MR; Huestis MA; Maurer HH
    J Mass Spectrom; 2011 Jul; 46(7):603-14. PubMed ID: 21656610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry.
    de Boer D; Tan LP; Gorter P; van de Wal RM; Kettenes-van den Bosch JJ; de Bruijn EA; Maes RA
    J Mass Spectrom; 1997 Nov; 32(11):1236-46. PubMed ID: 9373962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.